Cargando…

Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study

INTRODUCTION: Whether melancholia is a distinct syndrome has long been debated. One aspect of a valid syndrome is whether it allows for determination of a prognosis. The aim of this study is to investigate the course of melancholic depression versus non-melancholic depression with a focus on: (i) ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nöbbelin, Linnéa, Bogren, Mats, Mattisson, Cecilia, Westling, Sofie, Brådvik, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437052/
https://www.ncbi.nlm.nih.gov/pubmed/37599865
http://dx.doi.org/10.3389/fpsyt.2023.1216431
_version_ 1785092424039661568
author Nöbbelin, Linnéa
Bogren, Mats
Mattisson, Cecilia
Westling, Sofie
Brådvik, Louise
author_facet Nöbbelin, Linnéa
Bogren, Mats
Mattisson, Cecilia
Westling, Sofie
Brådvik, Louise
author_sort Nöbbelin, Linnéa
collection PubMed
description INTRODUCTION: Whether melancholia is a distinct syndrome has long been debated. One aspect of a valid syndrome is whether it allows for determination of a prognosis. The aim of this study is to investigate the course of melancholic depression versus non-melancholic depression with a focus on: (i) time to and probability of recovery from the first depressive episode, (ii) time to and risk of the first recurrence, (iii) rate of recurrence, (iv) time with depression or antidepressant medication, and (v) suicide risk. METHODS: The Lundby Study is a longitudinal community study on mental health that followed a geographically defined population (N = 3,563) for up to 50 years, 1947–1997. Subjects with first onset depression were assessed as melancholic (N = 46) or non-melancholic (N = 381) using the DSM-IV melancholic specifier. These diagnoses were made in retrospect using all available information from semi-structured interviews by psychiatrists, key informants, registers, and patient records. RESULTS: We found no significant difference between melancholic- and non-melancholic depression in time to and probability of recovery from the first depressive episode. The time to first recurrence was shorter in melancholic than in non-melancholic depression and the risk of first recurrence for the melancholic group was 2.77 (95% confidence interval [CI] 1.83–4.20) times the risk in the non-melancholic group. The median rate of recurrence was higher in the melancholic group, at 0.19 recurrences per year at risk (interquartile range [IQR] 0.08–0.47), compared to the non-melancholic group, at 0.10 recurrences per year at risk (IQR 0.05–0.21) (p < 0.03). The median percentage of time being depressed or on antidepressant medication was higher in the melancholic group, 17% (IQR 3–20%), compared to the non-melancholic group, 8% (IQR 7–33%) (p < 0.001). The risk of suicide was higher in the melancholic group, hazard ratio 4.13 (95% CI 1.49–11.48, p < 0.01). DISCUSSION: To conclude, melancholic depression had a more recurrent, chronic, and severe course with a higher suicide risk than did non-melancholic depression in the Lundby population. Although our use of retrospective diagnosis might limit interpretation of results, the findings indicate that melancholia may be useful in determining prognosis and may be a valid psychopathological syndrome.
format Online
Article
Text
id pubmed-10437052
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104370522023-08-19 Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study Nöbbelin, Linnéa Bogren, Mats Mattisson, Cecilia Westling, Sofie Brådvik, Louise Front Psychiatry Psychiatry INTRODUCTION: Whether melancholia is a distinct syndrome has long been debated. One aspect of a valid syndrome is whether it allows for determination of a prognosis. The aim of this study is to investigate the course of melancholic depression versus non-melancholic depression with a focus on: (i) time to and probability of recovery from the first depressive episode, (ii) time to and risk of the first recurrence, (iii) rate of recurrence, (iv) time with depression or antidepressant medication, and (v) suicide risk. METHODS: The Lundby Study is a longitudinal community study on mental health that followed a geographically defined population (N = 3,563) for up to 50 years, 1947–1997. Subjects with first onset depression were assessed as melancholic (N = 46) or non-melancholic (N = 381) using the DSM-IV melancholic specifier. These diagnoses were made in retrospect using all available information from semi-structured interviews by psychiatrists, key informants, registers, and patient records. RESULTS: We found no significant difference between melancholic- and non-melancholic depression in time to and probability of recovery from the first depressive episode. The time to first recurrence was shorter in melancholic than in non-melancholic depression and the risk of first recurrence for the melancholic group was 2.77 (95% confidence interval [CI] 1.83–4.20) times the risk in the non-melancholic group. The median rate of recurrence was higher in the melancholic group, at 0.19 recurrences per year at risk (interquartile range [IQR] 0.08–0.47), compared to the non-melancholic group, at 0.10 recurrences per year at risk (IQR 0.05–0.21) (p < 0.03). The median percentage of time being depressed or on antidepressant medication was higher in the melancholic group, 17% (IQR 3–20%), compared to the non-melancholic group, 8% (IQR 7–33%) (p < 0.001). The risk of suicide was higher in the melancholic group, hazard ratio 4.13 (95% CI 1.49–11.48, p < 0.01). DISCUSSION: To conclude, melancholic depression had a more recurrent, chronic, and severe course with a higher suicide risk than did non-melancholic depression in the Lundby population. Although our use of retrospective diagnosis might limit interpretation of results, the findings indicate that melancholia may be useful in determining prognosis and may be a valid psychopathological syndrome. Frontiers Media S.A. 2023-08-04 /pmc/articles/PMC10437052/ /pubmed/37599865 http://dx.doi.org/10.3389/fpsyt.2023.1216431 Text en Copyright © 2023 Nöbbelin, Bogren, Mattisson, Westling and Brådvik. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Nöbbelin, Linnéa
Bogren, Mats
Mattisson, Cecilia
Westling, Sofie
Brådvik, Louise
Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title_full Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title_fullStr Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title_full_unstemmed Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title_short Is melancholia a distinct syndrome? Recurrence, chronicity, and severity give evidence in the 50 year follow-up of the Lundby Study
title_sort is melancholia a distinct syndrome? recurrence, chronicity, and severity give evidence in the 50 year follow-up of the lundby study
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437052/
https://www.ncbi.nlm.nih.gov/pubmed/37599865
http://dx.doi.org/10.3389/fpsyt.2023.1216431
work_keys_str_mv AT nobbelinlinnea ismelancholiaadistinctsyndromerecurrencechronicityandseveritygiveevidenceinthe50yearfollowupofthelundbystudy
AT bogrenmats ismelancholiaadistinctsyndromerecurrencechronicityandseveritygiveevidenceinthe50yearfollowupofthelundbystudy
AT mattissoncecilia ismelancholiaadistinctsyndromerecurrencechronicityandseveritygiveevidenceinthe50yearfollowupofthelundbystudy
AT westlingsofie ismelancholiaadistinctsyndromerecurrencechronicityandseveritygiveevidenceinthe50yearfollowupofthelundbystudy
AT bradviklouise ismelancholiaadistinctsyndromerecurrencechronicityandseveritygiveevidenceinthe50yearfollowupofthelundbystudy